Home » Topics » Regulatory

Regulatory
RSS

Nexavar receives FDA approval for advanced renal cell carcinoma

Dec. 22, 2005

Depakote ER receives new approval in bipolar disorder

Dec. 19, 2005

Iplex approved for severe primary IGF-1 deficiency

Dec. 15, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

U.K. approval for MT-100 for migraine

Nov. 29, 2005

Metvix approved for Bowen's disease in Europe

Nov. 29, 2005

Effexor XR approved for adults with panic disorder

Nov. 22, 2005

BioMimetic's GEM-21S approved for periodontal bone defects

Nov. 22, 2005

Shanghai Sunway Biotech's H101 approved for refractory nasopharyngeal cancer

Nov. 18, 2005

Procoralan receives European approval for chronic stable angina

Nov. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...